Flock Feed Overlaps Watchlist Portfolio Insider Calendar Search Account

Feed
Overlap
Watch
Folio
Insider
Cal
Search
Me

Flock — Smart-money disclosures, made readable

Travere Therapeutics Inc

TVTXNASDAQ · US

Sign in for alerts Sign in to add to portfolio

Holders

Oaktree Capital Management
13F filer
$10.4M
9,213,000 sh
as-of 30 Sept 2025Stale
Two Sigma Investments
13F filer
$3.8M
3,000,000 sh
as-of 31 Mar 2026Quarterly
BlackRock
13F filer
$2.4M
3,700,000 sh
as-of 30 Jun 2024Stale

Ownership

Ownership data not yet available for this security.

Disclosure timeline

DISCLOSEDQuarterly
Two Sigma Investments
Travere Therapeutics Inc · NASDAQ
3,000,000 sh · $3.8M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
Oaktree Capital Management
Travere Therapeutics Inc · NASDAQ
9,213,000 sh · $10.4M
Filed 30 Sept 2025SEC 13Fview source
DISCLOSEDStale
Oaktree Capital Management
Travere Therapeutics Inc · NASDAQ
7,741,000 sh · $7.4M
Filed 30 Jun 2025SEC 13Fview source
DISCLOSEDStale
BlackRock
Travere Therapeutics Inc · NASDAQ
3,700,000 sh · $2.4M
Filed 30 Jun 2024SEC 13Fview source

Announcements

No announcements on record for this security.

TVTXNASDAQ · US

Sign in for alerts Sign in to add to portfolio

Latest filing31 Mar 2026Stale

3 disclosed holders · 4 disclosures · 0 announcements

Ownership

Ownership data not yet available for this security.

Announcements

No announcements on record for this security.